Laurie M. Strawn - Concepedia

Author

Laurie M. Strawn

Maxygen (United States)

Also Known As

L M Strawn, L.M. Strawn, Laurie M Strawn, Laurie M. Strawn, Laurie Strawn

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Maxygen (United States)Pfizer (United States)

About

Laurie M. Strawn is an author at Maxygen (United States) specializing in medicine, cell biology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	1.1K
2	Cell Biology	4	4	1K
3	Pathology	3	3	996
4	Natural Sciences	2	2	572
5	Biochemistry	1	1	75

Laurie M. Strawn

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors. Alexander Laird, Peter Vajkoczy, Laura K. Shawver, PubMed PathologyCancer BiologyTumor BiologyAngiogenesisReceptor Tyrosine Kinase	2000	497
Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo. B Millauer, M P Longhi, Karl H. Plate, PubMed PathologyCancer BiologyGliomaDominant-negative MethodologyTumor Biology	1996	424
Inhibition of glioma cell growth by a truncated platelet-derived growth factor-beta receptor. Laurie M. Strawn, E Mann, Susan S. Elliger, Journal of Biological Chemistry	1994	116
Receptor tyrosine kinases as targets for inhibition of angiogenesis Laura K. Shawver, Kenneth E. Lipson, T. Annie T. Fong, Drug Discovery Today AngiogenesisMedicineReceptor Tyrosine KinaseVascular BiologyReceptor Tyrosine Kinases	1997	78
Tyrosine kinases in disease: overview of kinase inhibitors as therapeutic agents and current drugs in clinical trials Laurie M. Strawn, Laura K. Shawver Expert Opinion on Investigational Drugs Kinase InhibitorsPathologyPharmacotherapyPharmaceutical ChemistryMedicinal Chemistry	1998	75
Effects of SU101 in combination with cytotoxic agents on the growth of subcutaneous tumor xenografts. Laurie M. Strawn, Fairooz F. Kabbinavar, D P Schwartz, PubMed Tumor XenograftsChemoprevention StrategyDermatologyGliomaTumor Biology	2000	21
Iodoaryl analogs of dioctanoylglycerol and 1-oleoyl-2-acetylglycerol as probes for protein kinase C Laurie M. Strawn, Robert E. Martell, Robert U. Simpson, Journal of Medicinal Chemistry	1989	12
The Relationship Between Development Start Lag and Approval Lag in Oncology Drug Development in Japan Keitaro Nakajima, Ramzi Dagher, Laurie M. Strawn, Therapeutic Innovation & Regulatory Science Preclinical TherapeuticsOncologyApproval LagDrug TrialMedicine	2015	11

Page 1